Pfizer B7471014
Started: 11/2020
Study Name: A phase 3, single-arm trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy children 15 months through 17 years of age
Indication: Pneumococcal
Principal Investigators: Luke Anschutz, Dave Meduna